Dark Forest Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,601
Closed -$2.16M 814
2026
Q1
$2.16M Sell
35,601
-68,403
-66% -$3.99M 0.19% 142
2025
Q4
$5.61M Buy
104,004
+59,431
+133% +$2.86M 0.26% 74
2025
Q3
$2.01M Sell
44,573
-24,559
-36% -$1.15M 0.08% 463
2025
Q2
$3.2M Buy
69,132
+59,260
+600% +$2.91M 0.13% 248
2025
Q1
$602K Buy
9,872
+6,172
+167% +$360K 0.03% 868
2024
Q4
$209K Sell
3,700
-9,134
-71% -$510K 0.03% 803
2024
Q3
$664K Buy
+12,834
New +$602K 0.08% 282
2023
Q3
Sell
-8,962
Closed -$573K 1093
2023
Q2
$573K Buy
8,962
+8,047
+879% +$540K 0.05% 583
2023
Q1
$63.4K Buy
915
+421
+85% +$29.7K 0.02% 790
2022
Q4
$35.5K Buy
+494
New +$37.2K 0.01% 457
2021
Q4
Sell
-1,271
Closed -$75K 1446
2021
Q3
$75K Buy
+1,271
New +$83.7K 0.03% 463

Other funds holding BMY

Dark Forest Capital Management's BMY Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 35,601 shares — an estimated $2.16M sold.

Dark Forest Capital Management first reported a position in BMY in Q3 2021 and held it in 11 quarters. The position peaked at $5.61M in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 35,601 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.16M.
  • Dark Forest Capital Management first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 11 quarters.
  • Dark Forest Capital Management's Bristol-Myers Squibb position peaked at $5.61M in Q4 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.